首页> 外文期刊>International Journal of Basic and Applied Biology: IJBAB >Binding of Ester and Non Ester Drugs to Human Serum Albumin
【24h】

Binding of Ester and Non Ester Drugs to Human Serum Albumin

机译:酯和非酯药物与人血清白蛋白的结合

获取原文
获取外文期刊封面目录资料

摘要

Binding of certain drugs to Human Serum Albumin (HSA) is a field of profound research. HSA is an abundantplasma protein made up of a single polypeptide chain having 585 amino acids. It also contains three homologous domains. Itmainly serves the function of delivery of drugs, fatty acids and hormones by binding to it’s specific binding sites. This versatileprotein also have enzymatic property which convert prodrugs into active component. This protein is crucial in pharmaceuticalsas it can bind to various drugs mainly at two binding sites (site I and II) and overall seven binding sites are spreaded across theprotein. The binding of different components to protein modifies their effectivity and delivery which inturn transforms theirpharmacokinetic and pharmacodynamic properties. HSA also possess esterase activity which break down drugs with estermoieties. Such phenomenon may be the cause of failure of pharmacological action of certain drugs. This poster aims to showinteraction of various ester, prodrugs and non ester drugs with HSA. It has been observed that there was remarkably nodifference between binding pattern of drugs from these different categories. Also, none of prodrug belongs to non ester class.Thus, prognosis of HSA binding can contribute drastically to the discovery of new drug candidates. While earlier HSA researchshows that HSA interacts with particular type of ligands, this study aims to elaborate potential of HSA to interact with moredrugs in order to improve their action. It has also been observed that Warfarin is binding preferably at site 1 and this result issimilar to reports by various researchers submitted earlier.
机译:某些药物与人血清白蛋白(HSA)的结合是深入研究的领域。 HSA是一种丰富的血浆蛋白,由具有585个氨基酸的一条多肽链组成。它还包含三个同源域。它主要通过结合特定的结合位点来发挥药物,脂肪酸和激素的输送功能。这种通用蛋白还具有酶促性质,可将前药转化为活性成分。该蛋白在药物中至关重要,因为它可以主要在两个结合位点(I和II位)与各种药物结合,并且整个七个结合位点遍布整个蛋白。不同组分与蛋白质的结合改变了它们的有效性和递送,这反过来改变了它们的药代动力学和药效学性质。 HSA还具有酯酶活性,可分解具有酯基的药物。这种现象可能是某些药物药理作用失败的原因。该海报旨在展示各种酯类,前药和非酯类药物与HSA的相互作用。已经观察到,来自这些不同类别的药物的结合模式之间没有显着差异。而且,前药都不属于非酯类。因此,HSA结合的预后可以极大地促进新药候选物的发现。虽然早期的HSA研究表明HSA与特定类型的配体相互作用,但这项研究旨在阐明HSA与更多药物相互作用的潜力,以改善其作用。还已经观察到华法林优选在位点1结合,并且该结果类似于较早提交的各种研究人员的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号